Antibodies
8 December 2012
Genentech’s Perjeta Significantly Extends Survival in People With HER2-Positive Metastatic Breast Cancer6 December 2012
Janssen Submits Applications Requesting Approval Of STELARA In U.S. And Europe For Treatment Of Active Psoriatic Arthritis6 December 2012
NKT Therapeutics Presents Data on Potential Antibody Treatment for Sickle Cell Disease29 November 2012
Pieris Presents Data and Reveals Targets for Anticalin Bispecific PRS-190 at European Antibody Congress29 November 2012
XOMA Announces Servier Has Initiated a Proof-of-Concept Gevokizumab Study in Patients With a History of Acute Coronary Syndrome28 November 2012
NovImmune Initiates Phase I Clinical Study with First-in-Class Anti-TLR4 Monoclonal Antibody27 November 2012
Avaxia Biologics Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis27 November 2012
Bayer receives approval for EYLEA in Europe for the Treatment of Wet Age-Related Macular Degeneration21 November 2012
First AT001/r84 dose in man in clinical trial in Russia16 November 2012
ZALTRAP (ziv-aflibercept) Receives CHMP Positive Opinion in the European Union for Previously Treated Metastatic Colorectal Cancer12 November 2012
ADACTA Study Showed ACTEMRA Improved Signs and Symptoms of Rheumatoid Arthritis Significantly More Than Adalimumab as a Single-Agent Therapy12 November 2012
Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group12 November 2012
MorphoSys Reports Successful Phase 1 Study of MOR103 Using a Subcutaneous Administration12 November 2012
Novartis data show ACZ885 delivered rapid and strong symptom relief while reducing frequency of attacks in two periodic fever syndromes12 November 2012
Merck Presents Early-Stage Interim Data for MK-3475, an Investigational Therapy for the Treatment of Advanced Melanoma12 November 2012
Synthon enters into global license agreement with Amgen and Watson for biosimilar trastuzumabNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports